Newsroom
August 8, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
July 31, 2024
Scientists from The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, led a pilot study of the Food and Drug Administration-approved antiretroviral drug lamivudine, to determine if it could be a potential treatment for Alzheimer’s disease. Almost half of what makes up the human genome are […]
July 15, 2024
Sudha Seshadri, MD, Department of Neurology, director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed for this article. Read More
July 12, 2024
Sudha Seshadri, MD, Department of Neurology, director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article. Read More
June 21, 2024
Study led partly by UT Health San Antonio suggests new prevention strategies Research led in part by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) finds that the most common cerebral small-vessel disease feature seen in brain magnetic resonance imaging is a primary vascular factor associated with dementia risk. […]
June 11, 2024
The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio was mentioned in this article. Read More